Skip to main content

David Hong

Analyst

Deutsche Bank

Equibles does not estimate personal net worth.

About David Hong

David Hong is recorded as Analyst at Deutsche Bank. David Hong has spoken on 4 earnings calls across 3 companies, most recently for Alkermes plc. on November 3, 2026. Those appearances were for Jazz Pharmaceuticals plc (JAZZ), Alkermes plc. (ALKS) and Axsome Therapeutics, Inc. (AXSM). The companies whose calls David Hong spoke on are classified in the Healthcare sector.

David Hong on recent calls

“I wanted to ask, once you are post Vibrance III data in IH, either year-end or early 27, once that data is in hand, How quickly would you look to move into a Phase III program for IH, and what would that study design potentially look like?”
Analyst — Deutsche Bank, Q3 2026 Alkermes plc Earnings Conference Call ·
“I wanted to drill down a little bit on the commentary about the threefold increase, I believe, in ordering accounts in September for ZIERA that you're seeing. How should we think about that step up in accounts translating over to revenues, and what would be the timeframe that that would occur in?”
Analyst — Deutsche Bank, Q3 2026 Jazz Pharmaceuticals Earnings Conference Call ·
“So, first, I wanted to come back to the peak sales number that you put out there for Avelity. If I heard you correctly, I think you said 50-50 for the, you know, MDD versus ADA indications.”
Analyst — Deutsche Bank, Axsome Therapeutics, Inc. Q1 FY2026 Earnings Call ·
“So maybe a follow-up to some of the questions here on the Sleep-Wake franchise. Just in terms of your payer contracts, you mentioned that you feel confident about the ones you have in place.”
Analyst — Deutsche Bank, Jazz Pharmaceuticals plc Q4 FY2025 Earnings Call ·

Affiliation history

  • Deutsche Bank

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity